| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10962621 | Vaccine | 2016 | 7 Pages |
Abstract
The effect of CRM protein-polysaccharide conjugate vaccines on Hib antibody responses varies greatly between vaccines. Co-administration of a CRM conjugate vaccine can produce either positive or negative effects on Hib antibody responses. These inconsistencies suggest that CRM itself may not be the main driver of variability in Hib responses, and challenge current perspectives on this issue.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Merryn Voysey, Manish Sadarangani, Elizabeth Clutterbuck, Barbara Bolgiano, Andrew J. Pollard,